Biotricity
A medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets.
Launch date
Employees
Market cap
$8.8m
Enterprise valuation
$34m (Public information from Sep 2024)
Share price
$0.313 BTCY
Redwood City California (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | 1.4m | 3.4m | 7.7m | 9.6m | 12.1m | 14.3m |
| % growth | (96 %) | 256 % | 139 % | 126 % | 26 % | 25 % | 19 % |
| EBITDA | (8.6m) | (10.9m) | (14.1m) | (19.2m) | (15.6m) | (8.9m) | - |
| % EBITDA margin | (2158 %) | (770 %) | (416 %) | (250 %) | (162 %) | (74 %) | - |
| Profit | (8.6m) | (11.1m) | (15.5m) | (29.1m) | (18.7m) | (14.1m) | - |
| % profit margin | (2158 %) | (781 %) | (458 %) | (381 %) | (194 %) | (117 %) | - |
| EV / revenue | 136.7x | - | 37.9x | 17.4x | 2.9x | 1.2x | 0.7x |
| EV / EBITDA | -6.3x | - | -9.1x | -6.9x | -1.8x | -1.6x | - |
| R&D budget | 1.3m | 1.4m | 2.1m | 2.7m | 3.2m | 2.6m | - |
| R&D % of revenue | 329 % | 96 % | 61 % | 36 % | 34 % | 21 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $45.0k Valuation: $90.0k | IPO | |
| N/A | $1.2m | Post IPO Debt | |
| N/A | $2.5m | Post IPO Equity | |
| N/A | $6.0m | Post IPO Equity | |
| N/A | $9.5m | Convertible | |
| N/A | $16.0m | Post IPO Equity | |
* | $12.0m | Post IPO Debt | |
* | $240k | Grant | |
| Total Funding | $9.7m | ||
Related Content
Recent News about Biotricity
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.